Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
Noah Berlow(Children's Cancer Therapy Development Institute), Charles Keller(University of Utah)
Cited by 19
Related Papers
Alveolar rhabdomyosarcomas in conditional <i>Pax3:Fkhr</i> mice: cooperativity of Ink4a/ARF and Trp53 loss of function
|Genes & Development|2004|299
Lineage of origin in rhabdomyosarcoma informs pharmacological response
|Genes & Development|2014|104
Cell-Cycle Dependent Expression of a Translocation-Mediated Fusion Oncogene Mediates Checkpoint Adaptation in Rhabdomyosarcoma
|PLoS Genetics|2014|46
Design considerations of an IL13Rα2 antibody–drug conjugate for diffuse intrinsic pontine glioma
|Acta Neuropathologica Communications|2021|40
Volasertib preclinical activity in high-risk hepatoblastoma
|Oncotarget|2019|31